In vivo Evidence of γ-Tocotrienol as a Chemosensitizer in the Treatment of Hormone-Refractory Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0313|85|4|248-258

ISSN： 0031-7012

Source： Pharmacology, Vol.85, Iss.4, 2010-04, pp. : 248-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment

By Guérin Olivier   Fischel Jean Louis   Ferrero Jean-Marc   Bozec Alexandre   Milano Gerard  

Pharmaceuticals, Vol. 3, Iss. 7, 2010-07 ,pp. : 2238-2247

MDPI

Access to resources Recommend Favorite

Octreotide in the Management of Hormone-Refractory Prostate Cancer

By  

Chemotherapy, Vol. 47, Iss. 2, 2001-03 ,pp. : 109-126

Karger

Access to resources Recommend Favorite

γ-Tocotrienol Inhibits Proliferation and Induces Apoptosis via the Mitochondrial Pathway in Human Cervical Cancer HeLa Cells

By Xu Weili   Mi Yaqing   He Pan   He Shenghua   Niu Lingling  

Molecules, Vol. 22, Iss. 8, 2017-08 ,pp. : 1299-1299

MDPI

Access to resources Recommend Favorite

Future Prospects for Luteinizing Hormone-Releasing Hormone Analogues in Prostate Cancer Treatment

By  

Pharmacology, Vol. 85, Iss. 2, 2010-02 ,pp. : 110-120

Karger

Access to resources Recommend Favorite

γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status

By Singh Vijay K.   Hauer-Jensen Martin  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 663-663

MDPI

Access to resources Recommend Favorite